FENNEC PHARMACEUTICALS INC. 8-K

What Happened
Fennec Pharmaceuticals Inc. announced its full-year and fourth-quarter financial results for the period ended December 31, 2025 via a press release dated March 24, 2026. The company filed a Current Report on Form 8-K on March 24, 2026 to furnish that press release (attached as Exhibit 99.1).

Key Details

• Filing date: March 24, 2026; reporting period: year and quarter ended December 31, 2025.
• The press release containing the results is attached to the 8-K as Exhibit 99.1.
• The 8-K states the information is being furnished (not filed) and therefore is not automatically incorporated by reference into other SEC filings unless later referenced.

Why It Matters
This 8-K notifies investors that Fennec has released its latest earnings and operating results for FY2025 and Q4 2025. Retail investors should read the attached press release for specific figures (revenue, net income/loss, guidance, and operational highlights) and watch for subsequent SEC filings (e.g., 10-K) for audited financial statements and more detailed disclosures. The announcement provides the most recent snapshot of the company’s financial performance, which can influence investor decisions and market reaction.